LUNG CANCER DAY
Immunochemotherapy and the search for biomarkers mark a paradigm shift in lung cancer. The possibilities offered by these treatments in combination with conventional tools, such as chemotherapy, have doubled the five-year survival of patients, as well as the median overall survival in advanced stages. Specifically, the application of immunotherapy and chemotherapy is already a standard […]
